Affordable universal fusion universal vaccine for foot and mouth disease infections

Abstract

The present invention relates to a pharmaceutical composition for inducing one or more immune responses capable of cross-protection against multiple strains or serotypes of a virus to generate protection with a single vaccination campaign. This universal vaccine comprises a composition presenting epitopes of antigens of all known sera of A, O, C, Asia, and the South African types of SAT-1, 2, and 3 capable of developing immunity against the Foot and Mouth Disease (FMD) in food-producing animals, such as cattle, sheep, goats, swine and other cloven-hoofed animals. The antigen vaccine is fused with serum proteins or short peptides to bind to serum proteins to enhance its half-life and with an adjuvant to enhance the activity of the vaccine when produced using recombinant technology. The RNA-based delivery of vaccines reduces the cost significantly, making this universal fusion vaccine affordable globally.

Dependencies are inferred from the claim text.